Nice find triage. I’m posting the link below because the pay wall didn’t come up through this link.
https://www.google.com.au/amp/s/www.nytimes.com/2021/01/11/health/colonoscopy-health-home-testing.amp.html
In my opinion, ColoSTAT is a game changer when you think about it’s unique advantages over FIT or colonoscopy, and the levels of accuracy it’s achieving in trials look highly promising that it’s going to be a market leader. Massive market here and globally. Very exciting stock to be holding. Thanks for the article.
New York Times article, page-2
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.044(57.9%) |
Mkt cap ! $28.58M | |||
| Open | High | Low | Value | Volume |
| 8.4¢ | 14.0¢ | 8.4¢ | $469.1K | 4.186M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7508 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 300000 | 1 |
View Market Depth
| Last trade - 12.43pm 07/10/2024 (20 minute delay) ? |
| RHY (ASX) Chart |